Latest Updates
-
The Sepsis Clock: Why Waiting to See If the Fever Settles Can Be Dangerous -
Ganesh Chaturthi 2026: Inside The Star-Studded Celebrations At Lalbaugcha Raja And Antilia -
The 5-Minute Childhood Skincare Routine: Why Simpler May Actually Be Better -
OTT Releases This Week (September 14–20): What To Watch Across Netflix, Prime Video, JioHotstar And More -
Fiji's HIV Cases Have Risen 16-Fold Since 2019 — Now It's A National Emergency -
Can a 50-Year-Old Develop Alzheimer's? What Early-Onset Dementia Looks Like -
Mahalaxmi Vrat 2026: Date, Puja Vidhi, And The Legend Behind The 16 Knots -
Who Is Anant Nag? Meet The Veteran Kannada Actor Set To Receive Dadasaheb Phalke Award -
Monsoon And Diabetes: Why Infection Risk Increases During The Rainy Season -
Throwback Thursday: Kareena Kapoor’s ‘Poo’ To Priyanka Chopra’s ‘Desi Girl’, Bollywood Looks That Ruled 2000s
Tobacco Plant May Help Fight Cancer
Tobacco plants, which are responsible for millions of cancer cases, may actually offer a therapy for patients with a chronic form of lymphoma, a new study suggests.
The National Academy of Sciences study suggests the tobacco plant could be used to tackle a form of lymphoma.
UK specialists said while "potentially exciting", more research would be needed to test how well the vaccine actually worked.
The ironic new role for tobacco is the work of researchers from Stanford University in California.
The researchers used the plants as factories for an antibody chemical specific to the cells, which cause follicular B-cell lymphoma, a type of non-Hodgkin's lymphoma.
These antibodies are put into a patient newly diagnosed with the disease, to "prime" the body's immune system to attack any cell carrying them.
If successful, this would mean the body would then recognise and destroy the lymphoma cells.
However, every patient's antibodies are different, and would need to be produced quickly once the diagnosis was made.
"It's pretty cool technology - and it's really ironic that you would make a treatment for cancer out of tobacco. That appealed to me," BBC quoted the study"s lead researcher Dr Ronald Levy, as saying.
The technique is relatively straightforward. Once a patient's cancer cells are isolated in the laboratory, the gene responsible for producing the antibody is extracted and added to the "tobacco mosaic virus".
The plants are then "infected" with the virus, and as it spreads through the cells, the added gene starts the process of producing large quantities of the antibody.
After just a few days a few leaves are taken, ground up, and the antibody extracted from them.
Only a few plants are needed to make enough vaccine for a patient.
Professor Charles Arntzen, from Arizona State University, said that the sheer speed of the production process could convince patients to wait for their own tailored vaccine rather than undergoing other treatment.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
